6892.TWO Taiwan Bio Therapeutics Co., Ltd

Healthcare Biotechnology Taiwan OTC Exchange
24.40 TWD
Close of Nov 6, 2026
23.15 30.50
Market cap
TWD 2.29B
P/E
-
P/B
2.90x
ROE
-52.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6892.TWO undervalued?

Graham number

The Graham number of Taiwan Bio Therapeutics Co., Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Taiwan Bio Therapeutics Co., Ltd fundamental analysis

No fundamental analysis for Taiwan Bio Therapeutics Co., Ltd yet.

Taiwan Bio Therapeutics Co., Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Taiwan Bio Therapeutics Co., Ltd

Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.

Full company profile